Dermorphin is an extremely potent opioid peptide — reported to be many times stronger than morphine. It has no approved human use and no legitimate dosing framework. This page intentionally contains no amounts, frequencies, or protocols. Non-medical use can cause fatal respiratory depression.
Overview
Unlike medicines with published clinical dosing, dermorphin has no approved human indication and therefore no legitimate dosing reference. Its known real-world context is illicit doping (notably in horse racing), where any "dosing" happened entirely outside medical oversight. The useful educational point is understanding why no protocol can responsibly be given.
Why no dosing pattern is given
Legitimate dosing comes from regulatory review, controlled trials, and product labeling. Dermorphin has none of these for humans. Providing a number would imply a safe use that does not exist and could directly enable harm. For an opioid this potent, there is no "start low" range that makes self-administration safe.
Potency as a lethal hazard
Because dermorphin is far more potent than morphine, vanishingly small quantities can produce strong opioid effects, including the respiratory depression that causes opioid deaths. High potency collapses the margin between an effect and an overdose, and unregulated material carries no reliable concentration or purity — so even careful measuring cannot make it predictable.
Why this is a clinical-only matter
Opioids are managed under prescription precisely because dosing, tolerance, and reversal (with agents like naloxone) require trained monitoring. Dermorphin sits outside even that system, with no approved role at all. Questions about pain or opioids belong with a qualified clinician — never a research-chemical vial.
Sport & Anti-Doping Warning
Dermorphin became notorious in horse racing as a potent opioid peptide (sometimes dubbed 'frog juice') illegally administered to racehorses to dull pain and enhance performance.
- >Equine industry discussion of dermorphin positives and zero-tolerance policies
- >Anti-doping guidance on narcotic analgesics and related peptides in competition
While most famous in veterinary sport, dermorphin and similar non-approved opioids would also be treated as prohibited narcotics in human athletics.